| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | mean survival time | saline | 1.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 19; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 2.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 19; 07/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 4.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 19; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q04DX003 (ip) | mean survival time | saline | 8.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 19; 08/08 animals surviving on tox evaluation day (usually day 5) |